Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E McCall

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Expert Opinion on Therapeutic Targets|March 17, 2020
Sirtuins: potential therapeutic targets for regulating acute inflammatory response?Vidula Vachharajani, Charles E McCall
Innate Immunity|April 19, 2019
Epigenetic and metabolic programming of innate immunity in sepsisVidula Vachharajani, Charles E McCall
Immunology and Cell Biology|September 14, 2011
MicroRNAs regulatory networks in myeloid lineage development and differentiation: regulators of the regulatorsMohamed El Gazzar, Charles E McCall
The Journal of Biological Chemistry|May 4, 2010
MicroRNAs distinguish translational from transcriptional silencing during endotoxin toleranceMohamed El Gazzar, Charles E McCall
Mitochondrion|March 2, 2023
The pyruvate dehydrogenase complex: Life's essential, vulnerable and druggable energy homeostatPeter W Stacpoole, Charles E McCall
Cytokine|November 17, 2010
Facultative heterochromatin formation at the IL-1 beta promoter in LPS tolerance and sepsisBarbara K Yoza, Charles E McCall
American Journal of Respiratory and Critical Care Medicine|January 27, 2007
Gene silencing in severe systemic inflammationCharles E McCall, Barbara K Yoza
Genes & Cancer|September 11, 2013
Deacetylation by SIRT1 Reprograms Inflammation and CancerTie Fu Liu, Charles E McCall
Expert Review of Clinical Immunology|August 5, 2014
Epigenetic coordination of acute systemic inflammation: potential therapeutic targetsVidula Vachharajani, Tiefu Liu, Charles E McCall
Journal of Endotoxin Research|April 15, 2003
Distinct post-receptor alterations generate gene- and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytesLiwu Li, Randy Jacinto, Barbara Yoza, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Expert Opinion on Therapeutic Targets|March 17, 2020
Sirtuins: potential therapeutic targets for regulating acute inflammatory response?Vidula Vachharajani, Charles E McCall
Innate Immunity|April 19, 2019
Epigenetic and metabolic programming of innate immunity in sepsisVidula Vachharajani, Charles E McCall
Immunology and Cell Biology|September 14, 2011
MicroRNAs regulatory networks in myeloid lineage development and differentiation: regulators of the regulatorsMohamed El Gazzar, Charles E McCall
The Journal of Biological Chemistry|May 4, 2010
MicroRNAs distinguish translational from transcriptional silencing during endotoxin toleranceMohamed El Gazzar, Charles E McCall
Mitochondrion|March 2, 2023
The pyruvate dehydrogenase complex: Life's essential, vulnerable and druggable energy homeostatPeter W Stacpoole, Charles E McCall
Cytokine|November 17, 2010
Facultative heterochromatin formation at the IL-1 beta promoter in LPS tolerance and sepsisBarbara K Yoza, Charles E McCall
American Journal of Respiratory and Critical Care Medicine|January 27, 2007
Gene silencing in severe systemic inflammationCharles E McCall, Barbara K Yoza
Genes & Cancer|September 11, 2013
Deacetylation by SIRT1 Reprograms Inflammation and CancerTie Fu Liu, Charles E McCall
Expert Review of Clinical Immunology|August 5, 2014
Epigenetic coordination of acute systemic inflammation: potential therapeutic targetsVidula Vachharajani, Tiefu Liu, Charles E McCall
Journal of Endotoxin Research|April 15, 2003
Distinct post-receptor alterations generate gene- and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytesLiwu Li, Randy Jacinto, Barbara Yoza, et al.
Pageof 11